These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27729421)

  • 1. Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus.
    Capodanno D; Angiolillo DJ
    Circulation; 2016 Nov; 134(20):1579-1594. PubMed ID: 27729421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?
    Leggio M; Bendini MG; Caldarone E; Lombardi M; Severi P; D'Emidio S; Stavri DC; Armeni M; Bravi V; Mazza A
    Diabetes Metab; 2018 Jun; 44(3):217-225. PubMed ID: 29257747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.
    Younis N; Williams S; Soran H
    Diabetes Obes Metab; 2009 Nov; 11(11):997-1000. PubMed ID: 19531055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.
    Saito Y; Okada S; Ogawa H; Soejima H; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Morimoto T;
    Circulation; 2017 Feb; 135(7):659-670. PubMed ID: 27881565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin in the prevention of cardiovascular events in patients with diabetes.
    Bell DS
    Postgrad Med; 2016; 128(2):180-90. PubMed ID: 26653848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
    Klomp CM; ten Cate H; Stehouwer CD; Schaper NC
    Ned Tijdschr Geneeskd; 2009; 153():A109. PubMed ID: 19785798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin for primary prevention of cardiovascular disease in diabetes mellitus.
    Pignone M; Williams CD
    Nat Rev Endocrinol; 2010 Nov; 6(11):619-28. PubMed ID: 20856266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Should we treat all diabetic patients with aspirin in primary prevention?].
    Righetti A; De Moerloose P; Philippe J
    Rev Med Suisse; 2005 Jun; 1(22):1500-4. PubMed ID: 16025889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of cardiovascular diseases in type 2 diabetes with aspirin].
    Duly-Bouhanick B; Menard S; Hadjadj S; Soares-Barbosa S; Plun-Favreau J; Guilloteau G
    Presse Med; 2001 Jan; 30(2):87-91. PubMed ID: 11244821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An aspirin a day? Clinical utility of aspirin therapy for the primary prevention of cardiovascular disease.
    Plazak ME; Mouradjian MT; Watson K; Reed BN; Noel ZR; Devabhakthuni S; Gale SE
    Expert Rev Cardiovasc Ther; 2019 Aug; 17(8):561-573. PubMed ID: 31305180
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of aspirin use with major bleeding in patients with and without diabetes.
    De Berardis G; Lucisano G; D'Ettorre A; Pellegrini F; Lepore V; Tognoni G; Nicolucci A
    JAMA; 2012 Jun; 307(21):2286-94. PubMed ID: 22706834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacology core reviews: aspirin.
    Gaglia MA; Clavijo L
    J Cardiovasc Pharmacol Ther; 2013 Nov; 18(6):505-13. PubMed ID: 24057863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin in people with diabetes: Time to clean up the prescription list?
    Vouillarmet J; Aboyans V
    Diabetes Res Clin Pract; 2019 Mar; 149():208-209. PubMed ID: 30753849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of guidelines on primary prevention of cardiovascular disease with aspirin: how much evidence is needed to turn a tanker?
    Matthys F; De Backer T; De Backer G; Stichele RV
    Eur J Prev Cardiol; 2014 Mar; 21(3):354-65. PubMed ID: 23610452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin.
    Evangelista V; Totani L; Rotondo S; Lorenzet R; Tognoni G; De Berardis G; Nicolucci A
    Thromb Haemost; 2005 Jan; 93(1):8-16. PubMed ID: 15630484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acetylsalicylic acid for the primary prevention of cardiovascular disease in diabetic patients].
    de Lange DW; Fiets WE; Banga JD
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1481-5. PubMed ID: 15481570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status.
    Xie M; Shan Z; Zhang Y; Chen S; Yang W; Bao W; Rong Y; Yu X; Hu FB; Liu L
    PLoS One; 2014; 9(10):e90286. PubMed ID: 25360605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An aspirin a day? Aspirin use across a spectrum of risk: cardiovascular disease, cancers and bleeds.
    Kolber MR; Korownyk C
    Expert Opin Pharmacother; 2014 Feb; 15(2):153-7. PubMed ID: 24206142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis.
    Younis N; Williams S; Ammori B; Soran H
    Expert Opin Pharmacother; 2010 Jun; 11(9):1459-66. PubMed ID: 20429671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.